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Abstract 
Background: A question of epidemiological relevance in Chagas disease studies is to understand Trypanosoma cruzi 
transmission cycles and trace the origins of (re)emerging cases in areas under vector or disease surveillance. Con‑
ventional parasitological methods lack sensitivity whereas molecular approaches can fill in this gap, provided that an 
adequate sample can be collected and processed and a nucleic acid amplification method can be developed and 
standardized. We developed a duplex qPCR assay for accurate detection and quantification of T. cruzi satellite DNA 
(satDNA) sequence in samples from domestic and sylvatic mammalian reservoirs. The method incorporates ampli‑
fication of the gene encoding for the interphotoreceptor retinoid‑binding protein (IRBP), highly conserved among 
mammalian species, as endogenous internal amplification control (eIAC), allowing distinction of false negative PCR 
findings due to inadequate sample conditions, DNA degradation and/or PCR interfering substances.
Results: The novel TaqMan probe and corresponding primers employed in this study improved the analytical sen‑
sitivity of the assay to 0.01 par.eq/ml, greater than that attained by previous assays for Tc I and Tc IV strains. The assay 
was tested in 152 specimens, 35 from 15 different wild reservoir species and 117 from 7 domestic reservoir species, 
captured in endemic regions of Argentina, Colombia and Mexico and thus potentially infected with different parasite 
discrete typing units. The eIACs amplified in all samples from domestic reservoirs from Argentina and Mexico, such as 
Canis familiaris, Felis catus, Sus scrofa, Ovis aries, Equus caballus, Bos taurus and Capra hircus with quantification cycles 
(Cq’s) between 23 and 25. Additionally, the eIACs amplified from samples obtained from wild mammals, such as small 
rodents Akodon toba, Galea leucoblephara, Rattus rattus, the opossums Didelphis virginiana, D. marsupialis and Mar-
mosa murina, the bats Tadarida brasiliensis, Promops nasutus and Desmodus rotundus, as well as in Conepatus chinga, 
Lagostomus maximus, Leopardus geoffroyi, Lepus europaeus, Mazama gouazoubira and Lycalopex gymnocercus, render‑
ing Cq’s between 24 and 33.
Conclusions: This duplex qPCR assay provides an accurate laboratory tool for screening and quantification of T. cruzi 
infection in a vast repertoire of domestic and wild mammalian reservoir species, contributing to improve molecular 
epidemiology studies of T. cruzi transmission cycles.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Parasites & Vectors
*Correspondence:  schijman@dna.uba.ar; aleschijman@gmail.com
1 Laboratorio de Biología Molecular de la Enfermedad de Chagas, INGEBI‑
CONICET, Buenos Aires, Argentina
Full list of author information is available at the end of the article
Page 2 of 9Wehrendt et al. Parasites Vectors          (2019) 12:567 
Background
Chagas disease, a neglected tropical disease caused by 
the protozoan parasite Trypanosoma cruzi is endemic 
in Latin America, where it is mainly transmitted by 
hematophagous insects belonging to the genera Tria-
toma, Rhodnius, Pastrongylus and Mepraia. Other 
transmission routes, such as congenital (from mother 
to child), oral (by consuming contaminated food) and 
through blood transfusions and organ transplantation, 
are also important. Approximately seven million peo-
ple are estimated to suffer from Chagas disease and 
hundreds of thousands of infected individuals have 
migrated to non-endemic countries [1].
The natural cycles of transmission involve sylvatic, 
domestic and peridomestic habitats. Opossums, arma-
dillos and rodents are major sylvatic reservoir hosts, 
whereas humans, dogs, cats and commensal (synan-
thropic) rodents are the main hosts in domestic or 
peridomestic habitats [2–4]. A major question of 
epidemiological relevance is whether these types of 
transmission cycles are connected or independent. 
Characterizing the level of interconnection/ independ-
ence of these transmission cycles is paramount to trace 
the origins of (re)emerging cases in areas under vector 
or disease surveillance [5, 6].
Assessing the infection status of potential mammalian 
reservoirs is essential. Molecular techniques, such as 
qPCR have much greater sensitivity than conventional 
parasitological methods [7–11]. However, the diverse 
composition of biological samples collected from differ-
ent mammalian reservoir species may affect amplifica-
tion accuracy, making it difficult to compare prevalence 
of infection among different species within a same area 
under study and/or between different geographical 
regions. Blood samples may contain substances act-
ing as qPCR inhibitors, leading to false negative results 
and sub-estimated prevalence rates. The quality of the 
sample may be altered during transportation from the 
site of blood collection to the molecular biology labo-
ratory and/or during DNA purification. Accordingly, 
an accurate method must include an internal amplifi-
cation control. In this context, we aimed to develop a 
duplex qPCR assay which would allow for simultane-
ous amplification of a T. cruzi DNA specific target and 
an endogenous internal control (eIAC) as amplifica-
tion standard. The design of novel TaqMan probe and 
primers targeting a satellite DNA (satDNA) sequence 
allowed for improved analytical sensitivity, beyond that 
of other previously developed assays based on the same 
target [12, 13], especially for TcI and TcIV strains [14]. 
The eIAC was based on a gene fragment encoding the 
interphotoreceptor retinoid-binding protein (IRBP), 
which is highly conserved among mammalian species 
and its usefulness as a DNA integrity control was previ-
ously reported in a conventional PCR assay [15]. Once 
standardized, the duplex assay has been evaluated in 
a panel of biological samples collected from different 
sylvatic and domestic mammalian species captured in 




Analysis of a standard panel of samples
A first evaluation of the duplex T. cruzi satDNA/IRBP 
qPCR assay (index test) was carried out using archival 
DNA from blood samples of well-characterized domestic 
and sylvatic mammalian species previously tested using 
standardized qPCR procedures (comparator test, [13]) in 
order to estimate their agreement.
Analysis of field samples
The index method was assayed using DNA extracted 
from peripheral blood samples preserved in guanidine 
hydrochloride 6M, EDTA 0.2 M (GE), pH 8.00 (blood:GE 
proportion of 1:3) and collected from domestic and syl-
vatic mammalian reservoirs captured in endemic regions 
from Argentina, Colombia and Mexico.
Argentinean wild and domestic samples were provided 
by Andrea Gomez-Bravo (Fundación Mundo Sano, Bue-
nos Aires, Argentina) from Añatuya, Santiago del Estero, 
Argentina. Colombian samples were provided by Felipe 
Guhl (Universidad de los Andes, Bogotá, Colombia). 
Mexican samples were collected from mammalian reser-
voirs captured in an endemic region for Chagas disease in 
Yucatán, Mexico and kindly provided by Janine M. Ram-
sey (Centro Regional de Investigación en Salud Pública, 
Chiapas, Mexico).
DNA extraction methods
DNA was extracted from 300 µl of whole blood/GE sam-
ples (blood:GE proportion of 1:3) using phenol-chlo-
roform based purification (for Mexican samples) or the 
High Pure PCR Template Preparation Kit (Roche Diag-
nostic Corp., Indiana, USA), following manufacturer 
instructions (for Argentinean and Colombian samples).
Keywords: Trypanosoma cruzi, Chagas disease, Mammalian reservoirs, Molecular epidemiology, Internal amplification 
standard, Multiplex qPCR, Parasite load
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Design of an endogenous internal amplification standard 
for duplex qPCR
A pair of primers and a TaqMan probe complementary 
to a highly conserved region within the amplified zone 
of the highly conserved mammalian IRBP gene were 
designed. Primer IRBP2 Fw was modified with respect 
to primer IRBP-CF-FWD reported by Ferreira et  al. 
[15] for molecular diagnosis of leishmaniasis. Primer 
IRBP3Rv and probe IRBPTq were designed from a con-
sensus sequence obtained after the alignment of IRBP 
sequences, available from 9 domestic and 8 wild mam-
malian reservoir species on GenBank (Table 1, Fig. 1). 
Duplex TaqMan qPCR assay
The reaction was performed in a final volume of 20 
µl with FastStart Universal Probe Master Mix (Roche 
Diagnostics, Mannheim, Germany) and 5 µl of DNA, in 
a Rotor-Gene 3000 (Corbett Life Science, Cambridge, 
UK) or an ABI 7500 (Applied Biosystems, Foster City, 
CA) device. For T. cruzi DNA amplification, new prim-
ers Cruzi1c, Cruzi2c [14] and probe Cruzi3 were used to 
enhance sensitivity with respect to a previous satDNA 
qPCR [12], in particular for Tc I and Tc IV strains. An 
internal amplification standard was amplified using prim-
ers IRBP Fw and Rv and IRBP probe. Their sequences and 
final concentrations in the qPCR reaction are given in 
Table 1. Cycling conditions were an initial step of 10 min 
at 95  °C and 45 cycles at 95  °C for 15 s and 56  °C for 1 
min.
Analytical parameters of duplex T. cruzi satDNA/IRBP qPCR 
assay
The satDNA single qPCR reaction was inclusive for 
strains belonging to discrete typing units DTUs TcI to 
TcVI, as previously reported [14]. To assess analyti-
cal sensitivity of the duplex format, blood from non-
infected dogs was spiked with cultured epimastigotes 
of CL Brener and Silvio X10 T. cruzi strains (TcVI and 
TcI, respectively) to a final concentration of  107 parasite 
equivalents/ml (par.eq/ml) and treated with three vol-
umes of guanidine hidrochloride 6 M-EDTA 0.2 M (pH 
8.00) (GE). Next, 10-fold serial dilutions were performed 
to cover a range between 0.001 to  106 par.eq/ml. DNA 
of each dilution was purified and amplified in duplicate 
by duplex qPCR. Theoretical versus measured Cq values 
were converted to log10 par.eq/ml and plotted for linear 
regression analysis. Analytical sensitivity was estimated 
using triplicate dilutions of the above-mentioned spiked 
samples for both parasites and analytical specificity was 
Table 1 Primer and probe sequences and concentrations used in duplex TaqMan qPCR assay for detection of T. cruzi DNA in 
mammalian reservoir species





Satellite repeat unit 
from T. cruzi genome
Primer Cruzi 1c TGA ATG GYG GGA GTC AGA G 0.75 98 Ramírez et al. [14]
Primer Cruzi 2c ATT CCT CCAAGMAGC GGA T 0.75
Probe Cruzi 3 FAM‑CAC ACA CTG GAC ACCAA‑NFQ‑MGB 0.05
IRBP gene from mam‑
malian genome
Primer IRBP2 Fw CCA AYA CVACC ACT GAG ATC TG 0.60 140 Present study
Primer IRBP3 Rv GCG CAT CTG YTT GAG GAT GTARG 0.60
Probe IRBP Tq HEX‑TGG TGG TCC TCA CCAG‑NFQ‑MGB 0.05
Fig. 1 IRBP sequence alignment for different wild and domestic reservoir species. Primer and probe annealing sequences are highlighted in bold 
letters. Nucleotides that differ from the primer or probe sequences are underlined
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estimated using DNA from T. rangeli, Leishmania major, 
L. donovani and L. amazonensis.
Quality controls of the duplex T. cruzi satDNA/IRBP qPCR 
assay
Each DNA extraction round included one blood sample 
from a seronegative dog as a negative extraction con-
trol. Each amplification round included two positive 
DNA controls containing 1 par.eq/ml and 100 par.eq/ml 
of CL Brener spiked dog samples and one non-template 
control.
The satDNA/IRBP qPCR results were considered as 
valid when the Cq of IRBP was within the expected 
range according to the criteria of Tukey: Cq’s.75th per-
centile + 1.5 × interquartile distance of median Cq, which 
would indicate inhibition or material loss in samples 
from the same experiment with n > 10 [16].
Trypanosoma cruzi DNA quantification of satDNA/IRBP 
qPCR positive samples
A panel of 22 satDNA/IRBP qPCR-positive samples 
was quantified for estimation of parasite load. For this, 
a standard quantification curve was constructed. Given 
that satDNA qPCR positive samples were genotyped as 
TcI [17, 18], DNA was obtained from non-infected dog 
blood spiked with  107 par.eq/ml of Silvio X10 clone (TcI) 
cultured parasites, and serially diluted in DNA obtained 
from blood collected from non-infected dogs aiming to 
cover a range of standards containing  10−1 to  105 par.eq/
ml.
Data analysis
To compare the agreement between the index duplex 
qPCR assay with comparator standardized qPCR proce-
dures in a panel of characterized samples, inter-observer 
kappa coefficients were calculated using GraphPad Soft-
ware online statistical calculators (http://www.graph pad.
com/quick calcs /kappa 1.cfm). Kappa values < 0.01 indi-
cate no agreement, those between 0.1 and 0.4 indicate 
weak agreement, those between 0.41 and 0.60 indicate 
clear agreement, those between 0.61 and 0.80 indicate 
strong agreement, and those between 0.81 and 1.00 indi-
cate nearly perfect agreement.
Results
Design and analytical performance of duplex T.cruzi 
satDNA/IRBP qPCR assay
IRBP primer and probe sequences were designed from 
a consensus IRBP sequence obtained after alignment 
of orthologous sequences from different mammalian 
species, available in the GenBank database (Table  1, 
Fig.  1). The reportable range of T. cruzi satDNA/IRBP 
qPCR assay was assessed in single and duplex formats 
(Additional file  1: Figure S1). No significant differences 
between single T. cruzi satDNA qPCR and duplex T. cruzi 
satDNA /IRBP qPCR were observed when comparing the 
Cq values obtained for different T. cruzi DNA concentra-
tions ranging between 10 and  105 par.eq/ml (Additional 
file 1: Figure S1).
The duplex T. cruzi sat DNA/IRBP qPCR analytical 
sensitivity was evaluated in dog blood samples spiked 
with cultured parasites from the Silvio X10 (TcI) and 
CL Brener (TcVI) stocks. The reportable range was from 
0.1 to  105 par.eq./ml and from 1 to  104 par.eq./ml for CL 
Brener and Silvio X10 stocks, respectively. Analytical 
sensitivities were 0.01 par.eq/ml for both T. cruzi stocks.
The assay amplified exclusively T. cruzi DNA sam-
ples; in contrast, it did not amplify DNA from different 
Leishmania species and T. rangeli (Table  2). Moreover, 
we compared the agreement between the duplex T. cruzi 
sat DNA/IRBP qPCR assay with previously reported 
PCR procedures in a panel of well-characterized blood 
samples from domestic and sylvatic mammal reservoirs 
(Table 3). An almost perfect agreement (% of agreement: 
97.83%; Cohen’s k: 0.95) was obtained.
Evaluation of blood samples from wild and domestic 
reservoirs
Blood sample panels from different mammalian species 
captured in three endemic regions for Chagas disease 
(Santiago del Estero, Argentina; Maní, Colombia; and 
Table 2 Analytical parameters of the duplex T.cruzi satDNA/IRBP 
qPCR assay
Analytical parameter satDNA/IRBP qPCR
Analytical sensitivity, par.eq./ml
 TcI (Silvio X10) 0.01
 TcVI (CL Brener) 0.01
Inclusivity (fg/µl)
 Tc I (Silvio X10) 0.25
 Tc II (Y) 0.125
 Tc III (M5631 cl5) 0.0625
 Tc IV (4167) 0.0625
 Tc V (MnCl2) 0.0625
 Tc VI (CL Brener) 0.0625
Exclusivity (non detectable qPCR) pg/µl
 T. rangeli 100
 L. major 1000
 L. donovani 1000
 L. amazonensis 100
Reportable range
 Cl Brener 0.1–105 par.eq/ml;
y = − 2.48X + 22.69; R2 = 0.99
 Silvio X10 1–104 par.eq/ml;
y = − 2.64 + 27.28; R2 = 0.98
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Yucatán, México) were tested for simultaneous detection 
of T. cruzi infection and IRBP amplification (Table 4).
The eIAC amplified in all samples from domestic res-
ervoirs from Argentina and Mexico, such as Canis famil-
iaris, Felis catus, Sus scrofa, Ovis aries, Equus caballus, 
Bos taurus and Capra hircus with Cq’s between 23 and 
25. It also amplified samples from wild mammals from 
Argentina, Colombia and Mexico, such as small rodents 
Akodon toba, Galea leucoblephara, Rattus rattus, the 
opossums Didelphis virginiana, D. marsupialis and Mar-
mosa murina, the bats, Tadarida brasiliensis, Promops 
nasutus and Desmodus rotundus, as well as in Conepatus 
chinga (skunk), Lagostomus maximus (viscacha), Leopar-
dus geoffroyi (wildcat), Lepus europaeus (hare), Mazama 
gouazoubira (brown brocket deer) and Lycalopex gym-
nocercus (Pampas fox) rendering Cq’s between 24 and 33 
(Table  4). The Tukey’s criterion [16] was used to detect 
samples with outlier Cq values for the eIAC, which would 
indicate PCR inhibition or material loss in samples from 
the same experiment with n > 10. Only one sample of 
Desmodus rotundus was considered invalid.
Samples from Colombian Didelphis marsupials, Mar-
mosa murina, Mexican dogs, cats and sheep that showed 
amplification of T. cruzi satDNA were considered posi-
tive (Table 4, [14]).
Quantification of parasite load
TaqMan qPCR allows for quantification of parasitic bur-
den in infected samples. Parasite loads were quantitated 
in infected sheep, dog and cat samples, as well as in 
Didelphis marsupialis and Marmosa murina (n = 22) 
(Fig.  2, Table  5). Except for both Ovis aries specimens, 
individuals from the other species presented heterogene-
ity in their parasite loads, ranging from 0.14 to 4.02  102 
par.eq/ml.
Discussion
Trypanosoma cruzi transmission cycles in sylvatic and 
domestic mammals have been studied in different eco-
epidemiological settings in endemic regions [5]. Initially, 
microscopic analysis, blood culture or xenodiagnosis 
were used for detection and isolation of T. cruzi strains 
from mammalian reservoirs [19, 20]. Later, studies devel-
oped in-house conventional amplification procedures for 
direct detection and genotyping of T. cruzi in domestic 
and wildlife reservoirs [6–9, 11, 21, 22] whereas in dogs 
qPCR assays were carried out [23, 24]. However, methods 
lacking internal amplification controls could not discrim-
inate between absence of infection and inadequate sam-
ples. Here, we have developed a TaqMan-based duplex 
qPCR procedure useful for detection and quantification 
of parasite loads in biological samples from wild and 
domestic mammalian reservoirs, coupled with an IRBP-
DNA-based internal amplification standard. This enables 
a distinction between true negative samples and false 
negative samples due to the presence of PCR interfering 
substances and/or degradation of DNA.
The assay was evaluated using 35 blood samples from 
15 different wild reservoir species and 117 samples 
from 7 domestic mammalian species. The IRBP-DNA-
based integrity control performed adequately in all 
above mentioned specimens except in one DNA sam-
ple from Desmodus rotundus. The IRBP Cq-values were 
variable in different species, in particular in wild res-
ervoirs, which may arise from different concentrations 
of nucleated cells in the blood of the different species 
[25, 26] and/or a different yield in blood-based DNA. 
In the case of column-based DNA extraction proce-
dures, the pigs and wildcats presented the lowest IRBP 
Cq-values (22.72 and 22.71, respectively) whereas the 
bat (Promops nasutus) showed the highest Cq-values 
(32.86). Nevertheless, in some cases, samples of the 
same species extracted using different DNA purifica-
tion methods yielded different Cq-values for IRBP-
DNA. In particular, phenol-chloroform-extracted DNA 
samples from Mexico yielded higher between-sample 
mean Cq- and SD-values than those obtained using 
column-based DNA extraction (Table  4). Previous 
comparison of DNA extraction methods from blood 
samples showed that those based in organic solvents 
rendered a higher degree of PCR inhibition [27, 28]. 
Thus, in comparative studies of parasitic burden among 
Table 3 Comparison of T. cruzi DNA detection by means of T. 
cruzi satDNA/IRBP qPCR assay (index test) and standardized qPCR 
(comparator test)
Note: Comparator qPCR test was reported in Ramirez et al. [13]
Panel of well‑characterized samples n Index test
Positive Negative
Comparator qPCR test‑positive
 Canis familiaris 2 2 0
 Felis catus 5 5 0
 Ovis aries 3 3 0
 Didelphis sp. 6 6 0
 Total 16 16 0
Comparator qPCR test‑negative
 Canis familiaris 9 0 9
 Felis catus 1 0 1
 Ovis aries 3 1 2
 Capra hircus 9 0 9
 Promops nasutus 6 0 6
 Conepatus chinga 1 0 1
 Lagostomus maximus 1 0 1
 Total 30 1 29
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individuals from the same species and/or among other 
reservoir species, the same DNA extraction procedure 
should be used and the acceptable range of IRBP Cq-
values should be estimated for each round and method 
of DNA extraction in order to detect outlier Cq-values 
that allow distinction of false negative samples [16]. We 
have explored the capacity of the IRBP internal control 
to detect DNA degradation by performing the following 
experiments: incubation of DNA samples for 48 hours 
at room temperature and exposition of DNA samples to 
UV light. In both cases the Cq-values of IRBP increased 
compared to outlier values (unpublished results).
Table 4 IRBP (eIAC) gene amplification in duplex satDNA/IRBP qPCR assay for T.cruzi DNA detection in samples from reservoir species
a  Phenol chloroform DNA extraction
b  One sample was IRBP negative
Note: IRBP amplification and detection of T.cruzi positive cases are shown
Abbreviations: SD, standard deviation; Cq, quantification cycle; nd, not determined
n satDNA/IRBP qPCR
IRBP control T cruzi 
positive/
totalValid samples Mean Cq SD
Wild reservoirs (n = 35)
Small rodents
 Akodon toba, Argentina 5 5 26.29 2.22 0/5
 Galea leucoblephara, Argentina 1 1 26.88 nd 0/1
 Rattus rattus, Argentina 1 1 24.72 nd 0/1
Marsupials
 Didelphis virginiana, México 4 4 24.29 1.27 0/4
 Didelphis marsupialis, Colombia 3 3 26.28 0.27 3/3
 Marmosa murina, Colombia 3 3 29.73 4.91 3/3
Bats
 Tadarida brasiliensis, Argentina 1 1 24.48 nd 0/1
 Promops nasutus, Argentina 4 4 33.60 1.97 0/4
 Desmodus rotundus (vampire), Argentina 2b 1 27.90 nd 0/1
Other mammals
 Conepatus chinga (skunk), Argentina 3 3 24.86 1.65 0/3
 Lagostomus maximus (viscacha), Argentina 3 3 28.38 0.20 0/3
 Leopardus geoffroyi (wildcat), Argentina 1 1 22.71 nd 0/1
 Lepus europaeus (hare), Argentina 1 1 27.88 nd 0/1
 Mazama gouazoubira (brown brocket deer), Argentina 1 1 26.78 nd 0/1
 Lycalopex gymnocercus (Pampas fox), Argentina 2 2 25.08 0.60 0/2
Domestic reservoirs (n =117)
 Bos taurus (cow), Argentina 12 12 24.84 0.31 0/12
 Canis lupus familiaris (dog), Argentina 27 27 24.52 1.10 0/27
 Canis lupus familiaris (dog), Méxicoa 4 4 28.85 4.50 4/4
 Capra hircus (goat), Argentina 24 24 23.75 1.13 0/24
 Equus caballus (horse), Argentina 2 2 23.40 0.49 0/2
 Felis catus (cat), Argentina 4 4 26.21 0.37 0/4
 Felis catus (cat), México 10 10 26.45 0.61 10/10
 Ovis aries (sheep), Argentina 29 29 25.16 0.92 0/29
 Ovis aries (sheep), Méxicoa 2 2 32.67 1.51 2/2
 Sus scrofa domesticus (pig), Argentina 3 3 22.72 0.98 0/3
Page 7 of 9Wehrendt et al. Parasites Vectors          (2019) 12:567 
On the other hand, high parasite loads may inhibit 
amplification of IRBP. This will not be a problem for qual-
itative detection of T. cruzi infection, but if accurate para-
site load quantifications are required, it is recommended 
to dilute the clinical sample and repeat the qPCR assay to 
achieve IRBP Cq-values within the acceptable range.
The high analytical sensitivity for satDNA amplification 
for both CL Brener and Silvio X10 stocks obtained with 
our assay had not been previously achieved, especially 
for TcI and TcIV strains [12, 13]. Probably, the exhaus-
tive alignment for satDNA sequences performed in this 
study, including a higher number of strains for each 
T. cruzi stock, contributed in this regard [14]. Indeed, 
to our knowledge, this is the first time that this set of 
satDNA-based PCR primers and probe have been used in 
biological specimens.
Conclusions
Our results indicate this novel assay is useful for T. cruzi 
infection screening in samples from different mammalian 
species, either in prospective studies or employing archi-
val DNA. Sample quality can be inferred by means of 
eIAC amplification. Moreover, the quantification of para-
site load may be indicative of the severity and the stage 
of infection in these reservoir species and their “trans-
mission potential” in their habitats, thus contributing to 
epidemiological knowledge of factors involved in T. cruzi 
transmission cycles.
Fig. 2 Quantification of parasite loads by means of duplex T. cruzi satDNA/IRBP qPCR in infected specimens. Quantification is expressed in parasite 
equivalents/ml of blood
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11 Ovis ariesa 31.61 29.45 0.14 − 0.853871964 TcI/TcVI
12 Ovis ariesa 33.74 29.13 0.21 − 0.677780705 TcI/TcVI
13 Canis familiarisa 29.60 27.47 0.84 − 0.075720714 TcVI
14 Canis familiarisa 28.83 29.31 0.18 − 0.744727495 TcI/TcVI
15 Canis familiarisa 24.69 29.27 0.19 − 0.721246399 TcI/TcVI
16 Canis familiaris 35.92 18.23 402.73 2.60500859 TcI
17 Didelphis marsupialis 26.01 26.80 0.96 − 0.017728767 nd
18 Didelphis marsupialis 26.54 21.29 46.41 1.666564777 nd
19 Didelphis marsupialis 26.30 22.04 27.39 1.437592032 nd
20 Marmosa murina 32.76 29.28 0.17 − 0.782516056 nd
21 Marmosa murina 32.37 29.17 0.21 − 0.688246139 nd
22 Marmosa murina 24.07 18.72 284.38 2.453891414 nd
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